{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-031301","form_type":"8-K","ticker":"SMTI","cik":"0000714256","company_name":"Sanara MedTech Inc.","filed_at":"2024-08-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.669492+00:00","generated_at":"2026-05-31T10:12:29.256465+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Sanara Q2 revenue up 28% to record $20.2M; net loss widens to $3.5M","bullets":["Revenue $20.2M, +28% YoY; eleventh consecutive record revenue quarter.","Net loss $3.5M vs $1.9M; Adjusted EBITDA $0.6M vs ($0.3M).","Secured $55M non-dilutive term loan from CRG; $15M drawn, up to $39.8M additional.","New GPO agreement adds over 1,000 contracted facilities; 300+ distributors, +70 since Jan.","Appointed Jake Waldrop as COO and Tyler Palmer as Chief Corporate Development & Strategy Officer."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-031301","json":"https://secwatch.observer/filing/0001493152-24-031301.json","markdown":"https://secwatch.observer/filing/0001493152-24-031301.md","text":"https://secwatch.observer/filing/0001493152-24-031301.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/714256/000149315224031301/0001493152-24-031301-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/714256/000149315224031301/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:12:29.256465+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}